| nonpneumonia(n = 104) | SAP (n = 50) | VAP (n = 10) | P value |
---|---|---|---|---|
Age (years) ± mean (SD) | 59.08 ± 10.65* | 68.46 ± 12.32 | 64.30 ± 15.64 | <0.001 |
Sex (male), n (%) | 83 (79.8%) | 33 (66.0%) | 8 (80.0%) | 0.165 |
Hypertension | 66 (63.5%) | 39 (78.0%) | 7 (70.0%) | 0.191 |
Diabetes | 28 (26.9%) | 20 (40.0%) | 3 (30.0%) | 0.259 |
Coronary Heart Disease | 10 (9.6%) | 6 (12.0%) | 2 (20.0%) | 0.582 |
Atrial Fibrillation | 16 (15.4%)* | 16 (32.0%) | 1 (10.0%) | 0.039 |
Hyperlipidemia | 35 (33.7%) | 8 (16.0%) | 2 (20.0%) | 0.061 |
Previous Stroke, n (%) | 23 (22.1%) | 15 (30.0%) | 5 (50.0%) | 0.123 |
Smoking status, n (%) | 64 (61.5%) | 26 (52.0%) | 6 (60.0%) | 0.529 |
Drinking status, n (%) | 50 (44.2%) | 15 (30.0%) | 4 (40.0%) | 0.266 |
NIHSS on Admission, median (IQR) | 6 (3,10)*# | 16 (8,23) | 21.5 (14.75-26) | <0.001 |
mRS on Admission, median (IQR) | 4 (3,4)*# | 5 (4,5) | 5 (4.75,5) | <0.001 |
GCS on Admission, median (IQR) | 15 (13,15)*# | 11.5 (7,14) | 8 (5.5,10.75) | <0.001 |
Dysphagia, n (%) | 22 (21.2%)*# | 32 (64.0%)& | 10 (100%) | <0.001 |
Enteral Nutrition, n (%) | 29 (27.9%)*# | 47 (94.0%) | 10 (100%) | <0.001 |
MV before pneumonia, n (%) | Â | 0 (0.0%) | 10 (100%) | Â |
MV after pneumonia, n (%) | Â | 42 (84.0%) | 10 (100%) | Â |
Oral hygiene care, n (%) | 104 (100%) | 50 (100%) | 10 (100%) | 1 |
Revascularization therapies, n (%) | Â | Â | Â | 0.106 |
 Intravenous Thrombolysis | 16 (15.4%) | 1 (2.0%) | 0 (0.0%) |  |
 Endovascular Thrombectom | 53 (51.0%) | 33 (66.0%) | 7 (70.0%) |  |
 Bridging Therapy | 11 (10.6%) | 7 (14.0%) | 2 (20.0%) |  |
 Drug Treatment | 24 (23.1%) | 9 (18.0%) | 1 (10.0%) |  |
Stroke subtype, n (%) | Â | Â | Â | 0.569 |
 Large artery disease | 65 (62.5%) | 34 (68.0%) | 8 (80.0%) |  |
 Cardioembolism | 21 (20.2%) | 11 (22.0%) | 1 (10.0%) |  |
 Small vessel occlusion | 10 (9.6%) | 1 (2.0%) | 0 (0.0%) |  |
 Others | 8 (7.7%) | 4 (8.0%) | 1 (10.0%) |  |
ICU length of stay, median (IQR) | 2 (1,3)*# | 7.5 (3,15) | 11 (5.75,17.5) | <0.001 |
30-day mRS, median (IQR) | 2 (1,3)*# | 5 (4,5) | 5 (4.75,6) | <0.001 |
90-day mRS, median (IQR) | 1 (0,2)*# | 5 (3,6) | 5 (4.75,6) | <0.001 |
30-day motality, n (%) | 4 (3.8%)*# | 7 (14.0%) | 3 (30.0%) | 0.005 |